CHINA PHARMA HOLDINGS, INC. (CPHI) › Cash & EquivalentsCHINA PHARMA HOLDINGS, INC. (CPHI) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $3.63M2010: $3.69M2011: $4.05M2012: $4.03M2015: $6.25M2016: $2.67M2017: $2.03M2018: $1.19M2019: $1.07M2020: $957.7K2021: $4.86M2022: $2.03M2023: $1.42M2024: $626.9K2025: $345.1K$345.1K2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$345.1K-44.9%2024$626.9K-56.0%2023$1.42M-29.9%2022$2.03M-58.2%2021$4.86M+407.4%2020$957.7K-10.9%2019$1.07M-9.4%2018$1.19M-41.6%2017$2.03M-23.8%2016$2.67M-57.3%2015$6.25M—2012$4.03M-0.5%2011$4.05M+9.7%2010$3.69M+1.6%2009$3.63M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share